Rocuronium Bromide Injection, Solution
Product Images NDC 51662-1355

Product Visual Gallery

This gallery contains 20 technical images submitted to the FDA as part of the official labeling for Rocuronium Bromide (NDC 51662-1355). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

10 mL Vial Label (10 mL Vial Label)

Not available.*

FDA Label Image

51662 1355 1 Vial Labeling Updated

This is a description of a medical product called "Vecuronium Bromide Injection" used as a muscle relaxant during anesthesia. It contains United States address and a warning message about possible allergic reactions. The rest of the text provides information about the product's identification code and its manufacturing details.*

FDA Label Image

C1 (Clinical Pharm 1)

Description: Rocuronium Bromide is a drug used for intubation. The table shows the percentage of patients with excellent/good intubating conditions and the time to completion after administration of the drug at different doses for adults, infants, and pediatric patients.*

FDA Label Image

C2 (Clinical Pharm 2)

This appears to be a table showing the dose, time to a certain level of muscle block, time to maximum block, and clinical duration of the muscle relaxant drug Rocuronium Bromide, administered intravenously in different doses for adults, geriatric patients, infants, and pediatric patients. However, without further context or explanation of the units used, it is difficult to provide a more detailed description.*

FDA Label Image

C10 (Clinical Pharma 10)

This appears to be a table showing pharmacokinetic (PK) parameters for patients in different age ranges, listed in days, months, and years. The table includes information on clearance (CL), volume of distribution (O), and half-life (1/2 B) for patients between 28 days old and 17 years old. The numbers in parentheses likely represent a range or variability in the values.*

FDA Label Image

C3 (Clinical Pharma 3)

This appears to be a chart showing the recommended dosage of rocuronium bromide for different age groups, from neonates to adolescents. It also shows the time it takes for maximum block and reappearance of T3 after administration over a period of time. However, some of the text is cut off, making it difficult to interpret some of the values.*

FDA Label Image

C4 (Clinical Pharma 4)

FDA Label Image

C5 (Clinical Pharma 5)

This is a figure showing the duration of clinical effect versus the initial dose of Rocuronium Bromide by age group. Median, 25th, and 75th percentiles, as well as individual values, are displayed. The age groups are categorized as 18-64 years, greater than or equal to 65 years, 3 months to 1 year, and 1-12 years, along with the dosages in milligrams per kilogram.*

FDA Label Image

C6 (Clinical Pharma 6)

FDA Label Image

C7 (Clinical Pharma 7)

This is a table that shows PK (pharmacokinetic) parameters for a certain drug in two groups of people: adults (aged 27-58 years) and geriatrics (aged 65 years and above). The table displays the clearance (L/kg/hr), volume of distribution at steady-state (L/kg), and half-life of elimination (hr) of the drug in each group.*

FDA Label Image

C8 (Clinical Pharma 8)

This is a table comparing PK parameters between patients with normal renal function, renal transplant, and hepatic dysfunction. It reports clearance, volume of distribution at steady state, and elimination half-life (t1/2 B) for each group of patients.*

FDA Label Image

C9 (Clinical Pharma 9)

This text provides pharmacokinetic parameters (clearance, volume of distribution and elimination half-life) for a medication for different age ranges of pediatric patients: 3 to 12 months, 1 to less than 3 years, and 3 to 8 years.*

FDA Label Image

Dosage 1 (Dosage And Administration 1)

This appears to be a table indicating the infusion delivery rate (mL/hr) for drug dosages based on the patient's weight (in pounds) and drug delivery rate (mcg/kg/min). The first row lists patient weights from 45 to 160 pounds in increments of 10, while the first column lists drug delivery rates from 4 to 100 mcg/kg/min in increments of 5. However, the table is not complete, as some values are missing.*

FDA Label Image

Dosage 2 (Dosage And Administration 2)

This table shows drug infusion rates based on patient weight, in pounds (Ibs), and drug delivery rate in mcg/kg/min. The infusion delivery rate is also provided in mL/hr. The lower rows of the table correspond to higher patient weights. Each column represents a different drug delivery rate.*

FDA Label Image

Dosage 3 (Dosage And Administration 3)

This table shows the drug delivery rates (mcg/kg/min) for patients of different weights (in lbs). The corresponding infusion delivery rates (mL/hr) for different weight ranges are also given in the table.*

FDA Label Image

Highlights (Highlights)

This is information related to the dosing and administration of a medication, specifically the dosage information for specific populations. The text also includes warnings and precautions regarding the risk of death due to medication errors and the possibility of residual paralysis.*

FDA Label Image

Logo (Logo)

FDA Label Image

Serialized Label (Serialized 10 mL Vial Label)

FDA Label Image

Serialized Vial Labeling 51662 1355 1 Update

FDA Label Image

Structure (Structure)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.